Mithrl develops an AI-powered Scientific Decision Engine for enterprise R&D teams in the biopharma and biotech sectors. The platform is designed to accelerate scientific discovery by transforming raw experimental data into defensible, actionable insights. It integrates advanced machine learning with deep biological knowledge to analyze omics data, delivering results the company states are 32 times faster than traditional methods.
The company's technical work spans AI, machine learning, biology, omics data analysis, and software engineering. Its core product provides auditable, reproducible analysis grounded in biology. A second offering, the AI Co-Scientist, allows researchers to use natural language queries to receive analysis, novel target candidates, and patent-ready reports.
Founded by scientists, Mithrl prioritizes scientific rigor alongside innovation and values collaboration between computational and biological experts. The company states its mission is to get new medicines to patients faster by creating tools that let scientists focus on research rather than manual workflows. Its platform is trusted by clients across three continents.
